Augusta University, USA
Rudolf Lucas obtained his PhD in cellular and genetic biotechnology in 1993 summa cum laude from the Free University of Brussels, Belgium (VUB) and he currently holds a faculty position at the Medical College of Georgia. He is currently Chair of the American Heart Association Lung Fellowship Committee. His expertise mainly
lies in the development of novel therapeutic candidates to treat pulmonary edema. Over the past 20 years, his research has led to the discovery of a TNF-derived peptide, Solnatide, which is a direct activator of the epithelial sodium channel. This peptide has shown promising activities in two recently finalized phase 2a clinical trials in patients with acute lung injury and upon lung transplantation.